Walgreens Boots Alliance, Inc.'s Stock Price Soars to $15.39, Marking a Positive 3.36% Swing in Market Performance | Smartkarma (2024)

Walgreens Boots Alliance, Inc. (WBA)

15.39 USD +0.50 (+3.36%) Volume: 12.12M

Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance stock price has been on a downward trend, with the company’s shares dropping over 3% recently. In an effort to combat this decline, Walgreens announced plans to cut prices on over 1,300 products as part of its Summer of Savings campaign. Despite this, profits at Boots, a subsidiary of Walgreens, have been soaring thanks to a boom in beauty sales. However, the stock price hit its lowest level since 1998, prompting investors to question whether it’s time to buy the dip or stay away. With high volumes of put options being bought on Walgreens Boots Alliance, the future remains uncertain as analysts debate whether the company is a smart investment or a value trap.

Walgreens Boots Alliance, Inc. on Smartkarma

Analysts on Smartkarma, such as Baptista Research, are closely monitoring Walgreens Boots Alliance. In their report “Redefining Relationships & Creating Value with Payers! – Major Drivers,” Baptista Research highlights the company’s second-quarter operational results meeting expectations despite challenges in the U.S. retail environment. The report emphasizes the company’s disciplined cost management and strong performance in the U.S. Retail Pharmacy segment, along with solid international performance. Baptista Research is evaluating various factors that could impact the company’s stock price in the near future using a Discounted Cash Flow methodology.

Another analyst, Travis Lundy, discusses Walgreens Boots Alliance in the report “The Health & Retail Revolution – Unveiling Their Path To Future Growth! – Major Drivers.” Lundy notes that the company exceeded Wall Street’s revenue and earnings expectations, demonstrating resilience in a tough U.S. retail landscape. The report highlights the company’s successful execution and cost discipline in the U.S. Retail Pharmacy segment, as well as strong international performance and progress in U.S. Healthcare profitability initiatives. Despite facing macroeconomic challenges, Walgreens’ management is focusing on strategic initiatives to drive future growth.

A look at Walgreens Boots Alliance, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Walgreens Boots Alliance has a strong outlook for its dividend and value factors, scoring a 5 and 4 respectively. This indicates that the company is performing well in terms of providing returns to its shareholders and being undervalued in the market. However, the growth, resilience, and momentum scores are lower at 2, 2, and 3 respectively. This suggests that the company may face challenges in terms of expanding its business, adapting to market changes, and maintaining a consistent growth trajectory.

Overall, Walgreens Boots Alliance, Inc. operates retail drugstores with a wide range of products and health services. While the company excels in providing dividends and is considered a good value investment, it may need to focus on improving its growth, resilience, and momentum factors to ensure long-term success in a competitive market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma